-+ 0.00%
-+ 0.00%
-+ 0.00%

RAPT Therapeutics Appoints Lori Lyons-Williams Chair Of The Board Of Directors

Benzinga·01/06/2025 13:07:38
Listen to the news

RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients with inflammatory and immunological diseases, today announced the appointment of Lori Lyons-Williams as chair of its board of directors, succeeding William Rieflin, who stepped down from the board effective January 3, 2025. Mr. Rieflin will remain as a consultant for the company.